Back
Adverum Biotechnologies Stock Predictions

Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
12
ADVM
Adverum Biotechnologies
Last Price:
$2.25
Seasonality Move:
-10.08%
7 Day Trial
ALL ACCESS PASS
$
7

Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compaAdverum Biotechnologies Stock Forecast
-
Is Adverum Biotechnologies Stock Undervalued?The current Adverum Biotechnologies [ADVM] share price is $2.25. The Score for ADVM is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
-
ADVM is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Adverum Biotechnologies Stock Go Up Next Year?
Data Unavailable
Adverum Biotechnologies Stock Rating
Data Unavailable
Adverum Biotechnologies Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
adverum.com
52-Week Data
52-Week High:
10.14
52-Week Low:
1.78
Prediction Charts
Market Cap:
47M
Price in USD:
2.25
Volume:
174K
Beta:
1.37
Technical Analysis
SMA50:
2.72
SMA100:
3.57
SMA200:
5.00
52-Wk Change:
-65.7%
Stock Predictions
-
Is Adverum Biotechnologies stock public?Yes, Adverum Biotechnologies is a publicly traded company.
-
What is the Adverum Biotechnologies stock quote today?The Adverum Biotechnologies stock price is 2.25 USD today.
-
How to buy Adverum Biotechnologies stock online?You can buy Adverum Biotechnologies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jun-2 | 2.25 | 2.43 | 2.50 | 2.23 |
Jun-3 | 2.45 | 2.51 | 2.63 | 2.36 |
Jun-4 | 2.51 | 2.47 | 2.54 | 2.43 |
Jun-5 | 2.48 | 2.42 | 2.51 | 2.37 |
Jun-6 | 2.49 | 2.83 | 2.83 | 2.48 |
Jun-9 | 2.85 | 2.97 | 2.98 | 2.76 |
Jun-10 | 2.97 | 2.79 | 3.10 | 2.77 |
Jun-11 | 2.82 | 2.59 | 2.82 | 2.57 |
Jun-12 | 2.53 | 2.59 | 2.63 | 2.53 |
Jun-13 | 2.53 | 2.46 | 2.62 | 2.41 |
Jun-16 | 2.51 | 2.47 | 2.51 | 2.41 |
Jun-17 | 2.45 | 2.32 | 2.46 | 2.31 |
Jun-18 | 2.33 | 2.29 | 2.46 | 2.21 |
Jun-20 | 2.33 | 2.25 | 2.52 | 2.24 |
Adverum Biotechnologies Earnings
Data Unavailable
Adverum Biotechnologies Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.40 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.58 per share, and an increase next year of $2.78 per share.
* Adverum Biotechnologies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.